Upload Avatar (500 x 500)
Chuandong Cheng
doctorcd@ustc.edu.cn
Chinese, English
Anhui
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 2001/09–2006/07 Bachelor in Clinical Medicine: Anhui Medical University
  • 2010/09–2013/07 Master in Surgery: Anhui Medical University, Supervisor: Chaoshi Niu
  • 2016/09–2020/11 Doctorate in Biology: University of Science and Technology of China, Supervisor: Kai Zhong
  • Hosted 3 hospital 'Three New' projects
  • Received 2 provincial awards
  • Received 1 medical new technology award
  • 2006/07–2013/11 - Anhui Provincial Hospital - Neurosurgeon
  • 2013/12–2018/11 - Anhui Provincial Hospital - Attending Neurosurgeon
  • 2018/12–Present - First Affiliated Hospital of University of Science and Technology of China - Associate Chief Neurosurgeon
  • 2023/10–Present - University of Science and Technology of China, School of Life Sciences and Medicine - Postdoctoral Researcher
  • Science and Technology Progress Award (2013): Third Prize by Anhui Provincial Government
  • Anhui Province Glioma Case Competition (2018): First Prize by Anhui Medical Association
  • National Glioma Surgery Competition (2022): Third Prize by Chinese Medical Association
Neurosurgery
Construction of a stratified diagnosis and treatment system for glioma based on molecular pathology and multimodal imaging characteristics
Regulation mechanism of glioma glycolipid metabolism on tumor and immune cell functions
New strategies for glioma treatment based on the regulation of immune and metabolic microenvironment
Application of multimodal imaging analysis of glioma based on machine learning
  • GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma, Xiaolong Qiao, Yinan Chen, Zixuan Wang, Nan Peng, Wanxiang Niu, Shiqiang Hou, Jiaying Wu, Ying Ji, Chaoshi Niu, Chuandong Cheng, 2023
  • Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma, Nianping Liu, Chen Jiang, Xinfeng Yao, Minghao Fang, Xiaolong Qiao, Lin Zhu, Zongcheng Yang, Xuyuan Gao, Ying Ji, Chaoshi Niu, Chuandong Cheng, Kun Qu, Jun Lin, 2023
  • SREBP2/Rab11s/GLUT1/6 network regulates proliferation and migration of glioblastoma, Chuandong Cheng, Junhong Tu, Zengchun Hu, Yinan Chen, Yue Wang, Ting Zhang, Caihua Zhang, Cong Li, Yang Wang, Chaoshi Niu, 2022
  • Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations, Chuandong Cheng, Chen C, Wang L, Dong YF, Yang Y, Chen YN, Niu WX, Wang WC, Liu QS, Niu CS, 2022
  • Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma via Targeting Androgen Receptor, Hu Z, Chuandong Cheng, Wang Y, Chen T, Tu J, Niu C, Xing R, Wang Y, Xu Y, 2021
  • LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression, Chuandong Cheng, Dong Y, Ru X, Xia Y, Ji Y, 2021
  • Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway, Cheng Chen, Chuandong Cheng, Hong Wu, Chen C, Cheng CD, Wu H, Wang ZW, Wang L, Jiang ZR, Wang AL, Hu C, Dong YF, Niu WX, Qi S, Qi ZP, Liu J, Wang WC, Niu CS, Liu QS, 2021
  • EZH2 is a potential prognostic predictor of glioma, Chen YN, Hou SQ, Jiang R, Sun JL, Chuandong Cheng, Qian ZR, 2021
Neurosurgery Glioma Molecular Pathology Multimodal Imaging Glycolipid Metabolism Immune Regulation Metabolic Microenvironment Machine Learning Diagnosis Treatment

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.